You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 685 A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model

Alerts

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Novel single-agent immunotherapies
685 A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address